JP2016196492A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016196492A5 JP2016196492A5 JP2016124235A JP2016124235A JP2016196492A5 JP 2016196492 A5 JP2016196492 A5 JP 2016196492A5 JP 2016124235 A JP2016124235 A JP 2016124235A JP 2016124235 A JP2016124235 A JP 2016124235A JP 2016196492 A5 JP2016196492 A5 JP 2016196492A5
- Authority
- JP
- Japan
- Prior art keywords
- atoms
- substituted
- unsubstituted
- het
- pyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161488997P | 2011-05-23 | 2011-05-23 | |
| US61/488,997 | 2011-05-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014512837A Division JP6054954B2 (ja) | 2011-05-23 | 2012-04-11 | ピリジン−及びピラジン誘導体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018061990A Division JP6763904B2 (ja) | 2011-05-23 | 2018-03-28 | ピリジン−及びピラジン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016196492A JP2016196492A (ja) | 2016-11-24 |
| JP2016196492A5 true JP2016196492A5 (https=) | 2017-12-07 |
Family
ID=45976540
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014512837A Expired - Fee Related JP6054954B2 (ja) | 2011-05-23 | 2012-04-11 | ピリジン−及びピラジン誘導体 |
| JP2016124235A Pending JP2016196492A (ja) | 2011-05-23 | 2016-06-23 | ピリジン−及びピラジン誘導体 |
| JP2018061990A Expired - Fee Related JP6763904B2 (ja) | 2011-05-23 | 2018-03-28 | ピリジン−及びピラジン誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014512837A Expired - Fee Related JP6054954B2 (ja) | 2011-05-23 | 2012-04-11 | ピリジン−及びピラジン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018061990A Expired - Fee Related JP6763904B2 (ja) | 2011-05-23 | 2018-03-28 | ピリジン−及びピラジン誘導体 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9273029B2 (https=) |
| EP (1) | EP2714677B1 (https=) |
| JP (3) | JP6054954B2 (https=) |
| KR (1) | KR101581522B1 (https=) |
| CN (1) | CN103748086B (https=) |
| AU (1) | AU2012259333B2 (https=) |
| BR (1) | BR112013029640A2 (https=) |
| CA (1) | CA2832605C (https=) |
| DK (1) | DK2714677T3 (https=) |
| EA (1) | EA023364B1 (https=) |
| ES (1) | ES2699256T3 (https=) |
| HR (1) | HRP20181884T1 (https=) |
| IL (1) | IL229528A (https=) |
| LT (1) | LT2714677T (https=) |
| MX (1) | MX352975B (https=) |
| PL (1) | PL2714677T3 (https=) |
| PT (1) | PT2714677T (https=) |
| RS (1) | RS58015B1 (https=) |
| SG (1) | SG194105A1 (https=) |
| SI (1) | SI2714677T1 (https=) |
| WO (1) | WO2012161877A1 (https=) |
| ZA (1) | ZA201307429B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012161877A1 (en) * | 2011-05-23 | 2012-11-29 | Merck Patent Gmbh | Pyridine-and pyrazine derivatives |
| GB201303109D0 (en) | 2013-02-21 | 2013-04-10 | Domainex Ltd | Novel pyrimidine compounds |
| NZ717552A (en) * | 2013-08-07 | 2021-07-30 | Merck Patent Gmbh | Piperidine urea derivatives |
| US9856223B2 (en) | 2013-12-13 | 2018-01-02 | Dana-Farber Cancer Institute, Inc. | Methods to treat lymphoplasmacytic lymphoma |
| EP3079682A4 (en) | 2013-12-13 | 2017-08-30 | Dana-Farber Cancer Institute, Inc. | Methods to treat lymphoplasmacytic lymphoma |
| CA2939164A1 (en) | 2014-02-12 | 2015-08-20 | Iteos Therapeutics | Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use |
| PE20170247A1 (es) | 2014-05-15 | 2017-03-29 | Iteos Therapeutics | Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1 |
| TW201613916A (en) | 2014-06-03 | 2016-04-16 | Gilead Sciences Inc | TANK-binding kinase inhibitor compounds |
| NZ729618A (en) | 2014-09-26 | 2018-07-27 | Gilead Sciences Inc | Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds |
| US9994547B2 (en) | 2014-10-06 | 2018-06-12 | Takeda Pharmaceutical Company Limited | Heteroarylamide inhibitors of TBK1 |
| US10112957B2 (en) | 2014-10-22 | 2018-10-30 | Dana-Farber Cancer Institute, Inc. | Thiazolyl-containing compounds for treating proliferative diseases |
| MA41598A (fr) * | 2015-02-25 | 2018-01-02 | Constellation Pharmaceuticals Inc | Composés thérapeutiques de pyridazine et leurs utilisations |
| WO2016147144A1 (en) | 2015-03-17 | 2016-09-22 | Pfizer Inc. | Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| EP3334733A1 (en) | 2015-08-10 | 2018-06-20 | Pfizer Inc | 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| EP3394044A1 (en) | 2015-12-17 | 2018-10-31 | Gilead Sciences, Inc. | Tank-binding kinase inhibitor compounds |
| WO2017102091A1 (en) | 2015-12-18 | 2017-06-22 | Bayer Pharma Aktiengesellschaft | Heteroarylbenzimidazole compounds |
| WO2017207534A1 (en) | 2016-06-03 | 2017-12-07 | Bayer Pharma Aktiengesellschaft | Substituted heteroarylbenzimidazole compounds |
| US10710980B2 (en) | 2016-07-20 | 2020-07-14 | Novartis Ag | Aminopyridine derivatives and their use as selective ALK-2 inhibitors |
| DE102016113714A1 (de) | 2016-07-26 | 2018-02-01 | Rosa Karl | Transfektionsverfahren mit nicht-viralen Genliefersystemen |
| GB201702947D0 (en) | 2017-02-23 | 2017-04-12 | Domainex Ltd | Novel compounds |
| TWI771410B (zh) * | 2017-04-27 | 2022-07-21 | 日商石原產業股份有限公司 | N-(4-吡啶基)菸鹼醯胺化合物或其鹽 |
| CN115038443A (zh) | 2019-11-22 | 2022-09-09 | 因西特公司 | 包含alk2抑制剂和jak2抑制剂的组合疗法 |
| JP2023530316A (ja) | 2020-06-16 | 2023-07-14 | インサイト・コーポレイション | 貧血の治療のためのａｌｋ２阻害剤 |
| CN116710090A (zh) * | 2020-10-09 | 2023-09-05 | Napa医疗有限公司 | Cd38的杂芳基酰胺抑制剂 |
| CN116099004B (zh) * | 2022-12-30 | 2024-01-30 | 深圳开悦生命科技有限公司 | Rna解旋酶dhx33抑制剂在制备用于治疗膀胱癌的药物中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| SE0102438D0 (sv) | 2001-07-05 | 2001-07-05 | Astrazeneca Ab | New compounds |
| SE0102439D0 (sv) | 2001-07-05 | 2001-07-05 | Astrazeneca Ab | New compounds |
| SE0203754D0 (sv) | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
| SE0203752D0 (sv) | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
| EP1715867A4 (en) * | 2004-02-12 | 2009-04-15 | Merck & Co Inc | BIPYRIDYLAMIDE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 |
| TW200800203A (en) * | 2006-03-08 | 2008-01-01 | Astrazeneca Ab | New use |
| EP2016075A1 (en) | 2006-05-03 | 2009-01-21 | AstraZeneca AB | Thiazole derivatives and their use as anti-tumour agents |
| WO2009030890A1 (en) | 2007-09-03 | 2009-03-12 | University Court Of The University Of Dundee | Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma |
| ATE523508T1 (de) | 2007-10-25 | 2011-09-15 | Astrazeneca Ab | Für die behandlung von zellproliferativen erkrankungen geeignete pyridin- und pyrazinderivate |
| WO2009122180A1 (en) * | 2008-04-02 | 2009-10-08 | Medical Research Council | Pyrimidine derivatives capable of inhibiting one or more kinases |
| ES2663222T3 (es) | 2008-12-19 | 2018-04-11 | Vertex Pharmaceuticals Incorporated | Derivados de pirazina útiles como inhibidores de la quinasa ATR |
| GB0903759D0 (en) * | 2009-03-04 | 2009-04-15 | Medical Res Council | Compound |
| WO2011089416A1 (en) | 2010-01-19 | 2011-07-28 | Astrazeneca Ab | Pyrazine derivatives |
| WO2012161877A1 (en) * | 2011-05-23 | 2012-11-29 | Merck Patent Gmbh | Pyridine-and pyrazine derivatives |
-
2012
- 2012-04-11 WO PCT/US2012/032983 patent/WO2012161877A1/en not_active Ceased
- 2012-04-11 EA EA201301302A patent/EA023364B1/ru not_active IP Right Cessation
- 2012-04-11 PL PL12715279T patent/PL2714677T3/pl unknown
- 2012-04-11 JP JP2014512837A patent/JP6054954B2/ja not_active Expired - Fee Related
- 2012-04-11 ES ES12715279T patent/ES2699256T3/es active Active
- 2012-04-11 DK DK12715279.1T patent/DK2714677T3/en active
- 2012-04-11 SG SG2013074638A patent/SG194105A1/en unknown
- 2012-04-11 CN CN201280025133.3A patent/CN103748086B/zh not_active Expired - Fee Related
- 2012-04-11 KR KR1020137030982A patent/KR101581522B1/ko not_active Expired - Fee Related
- 2012-04-11 LT LTEP12715279.1T patent/LT2714677T/lt unknown
- 2012-04-11 HR HRP20181884TT patent/HRP20181884T1/hr unknown
- 2012-04-11 RS RS20181427A patent/RS58015B1/sr unknown
- 2012-04-11 MX MX2013012979A patent/MX352975B/es active IP Right Grant
- 2012-04-11 SI SI201231465T patent/SI2714677T1/sl unknown
- 2012-04-11 PT PT12715279T patent/PT2714677T/pt unknown
- 2012-04-11 EP EP12715279.1A patent/EP2714677B1/en active Active
- 2012-04-11 US US14/118,845 patent/US9273029B2/en not_active Expired - Fee Related
- 2012-04-11 AU AU2012259333A patent/AU2012259333B2/en not_active Ceased
- 2012-04-11 BR BR112013029640A patent/BR112013029640A2/pt active Search and Examination
- 2012-04-11 CA CA2832605A patent/CA2832605C/en active Active
-
2013
- 2013-10-04 ZA ZA2013/07429A patent/ZA201307429B/en unknown
- 2013-11-21 IL IL229528A patent/IL229528A/en active IP Right Grant
-
2016
- 2016-06-23 JP JP2016124235A patent/JP2016196492A/ja active Pending
-
2018
- 2018-03-28 JP JP2018061990A patent/JP6763904B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016196492A5 (https=) | ||
| JP2018115201A5 (https=) | ||
| JP2014518884A5 (https=) | ||
| JP7169412B2 (ja) | 抗癌活性及び抗増殖活性を呈する２－アミノピリミジン－６－オン及び類似体 | |
| JP2016513660A5 (https=) | ||
| JP2016506369A5 (https=) | ||
| JP2013530176A5 (https=) | ||
| JP2016521710A5 (https=) | ||
| RU2015138964A (ru) | Полициклические модуляторы рецептора эстрогена и их применения | |
| JP2013528204A5 (https=) | ||
| JP2016535772A5 (https=) | ||
| HRP20171248T1 (hr) | Amino-supstituirani imidazopiridazini | |
| JP2016540811A5 (https=) | ||
| JP2013523814A5 (https=) | ||
| JP2015515961A5 (https=) | ||
| JP2014520863A5 (https=) | ||
| JP2012505891A5 (https=) | ||
| JP2009526072A5 (https=) | ||
| JP2017501237A5 (https=) | ||
| JP2011525502A5 (https=) | ||
| JP2016526576A5 (https=) | ||
| JP2011502956A5 (https=) | ||
| JP2014511869A5 (https=) | ||
| JP2013501720A5 (https=) | ||
| AR093512A1 (es) | Derivados heterociclicos como moduladores de la actividad de cinasas |